logo-loader

Zelira Therapeutics Ltd.

Receive alerts
Market:
ASX
Market Cap:
$42.5 m
Price
0.06 AUD
Change
6.67%
52 weeks high
0.09
52 weeks low
0.03

In brief

Zelira Therapeutics Ltd (ASX:ZLD) is a medicinal cannabis company focused on first-in-class human clinical trials for insomnia, autism and opioid reduction

Deep dive We explore the investor case for growth companies

Snapshot

Zelda has released its December quarterly report confirming multiple trials are on track.